Barbiturates and pyrazolopyridines for the treatment of postpartum depression—repurposing of two drug classes

Zulresso (brexanolone) is an aqueous formulation of the neurosteroid, allopregnanolone, and the only FDA-approved medication for the treatment of postpartum depression (PPD). While brexanolone is effective for the treatment of PPD, lengthy infusion time and high cost can be prohibitive. Failure of G...

Descripción completa

Detalles Bibliográficos
Autores principales: Horwitz, Alexander B., Rubin, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995982/
https://www.ncbi.nlm.nih.gov/pubmed/36909181
http://dx.doi.org/10.3389/fphar.2023.1139889

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995982/
https://www.ncbi.nlm.nih.gov/pubmed/36909181
http://dx.doi.org/10.3389/fphar.2023.1139889

Ejemplares similares